Bare Financial Services’s Nuvation Bio NUVB Stock Holding History

Bare Financial Services’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-53	Closed	-$475	–	1833
2025 Q4	$475	Buy	+53	New	+$328	﹤0.01%	1450

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bare Financial Services's NUVB Position: Q1 2026 in Review

Bare Financial Services sold out of Nuvation Bio (NUVB) in Q1 2026, closing a stake of 53 shares — an estimated $475 sold.

Bare Financial Services first reported a position in NUVB in Q4 2025 and held it in 1 quarter. The position peaked at $475 in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

Bare Financial Services reported no remaining Nuvation Bio position as of Q1 2026 after selling out during the quarter.
Bare Financial Services sold 53 Nuvation Bio shares in Q1 2026, an estimated $475.
Bare Financial Services first reported a position in Nuvation Bio in Q4 2025 and held it in 1 quarter.
Bare Financial Services's Nuvation Bio position peaked at $475 in Q4 2025.
231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Bare Financial Services's 13F filing for Q1 2026, filed 14 May 2026.